DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,292,246 | -42.6% | 33,423 | -44.5% | 0.02% | -57.7% |
| Q2 2023 | $14,448,000 | -87.8% | 60,200 | -87.2% | 0.05% | -89.8% |
| Q1 2023 | $118,721,678 | +1558.9% | 471,043 | +1647.0% | 0.51% | +1244.7% |
| Q4 2022 | $7,156,519 | -46.7% | 26,963 | -33.9% | 0.04% | -63.5% |
| Q4 2021 | $13,429,000 | -58.1% | 40,817 | -61.3% | 0.10% | -74.1% |
| Q3 2021 | $32,069,000 | +123.0% | 105,339 | +96.6% | 0.40% | +145.1% |
| Q2 2021 | $14,379,000 | +1042.1% | 53,581 | +857.7% | 0.16% | +720.0% |
| Q1 2021 | $1,259,000 | -89.9% | 5,595 | -90.0% | 0.02% | -88.7% |
| Q4 2020 | $12,475,000 | +3148.7% | 56,159 | +3046.2% | 0.18% | +3440.0% |
| Q3 2020 | $384,000 | -48.7% | 1,785 | -57.8% | 0.01% | -54.5% |
| Q2 2020 | $748,000 | +106.6% | 4,231 | +68.8% | 0.01% | -95.4% |
| Q3 2019 | $362,000 | +65.3% | 2,506 | +63.9% | 0.24% | +363.5% |
| Q2 2019 | $219,000 | -86.6% | 1,529 | -87.6% | 0.05% | -75.9% |
| Q1 2019 | $1,633,000 | +116.0% | 12,369 | +77.8% | 0.22% | +113.9% |
| Q3 2018 | $756,000 | +593.6% | 6,958 | +523.5% | 0.10% | +140.5% |
| Q1 2018 | $109,000 | – | 1,116 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |